Estate Counselors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
ACA
CHP
MCM
Estate Counselors's XBI Position: Q4 2023 in Review
Estate Counselors sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2023, closing a stake of 127,720 shares — an estimated $9.33M sold.
Estate Counselors first reported a position in XBI in Q2 2022 and held it in 6 quarters. The position peaked at $16M in Q1 2023. 745 funds tracked by Wall St. Rank hold XBI as of Q4 2023.
- Estate Counselors reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2023 after selling out during the quarter.
- Estate Counselors sold 127,720 State Street SPDR S&P Biotech ETF shares in Q4 2023, an estimated $9.33M.
- Estate Counselors first reported a position in State Street SPDR S&P Biotech ETF in Q2 2022 and held it in 6 quarters.
- Estate Counselors's State Street SPDR S&P Biotech ETF position peaked at $16M in Q1 2023.
- 745 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2023.
Based on Estate Counselors's 13F filing for Q4 2023, filed 23 Jan 2024.